CGS-20625

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCGS-20625
Drug Alias NameCGS-20625
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGABA-A receptor; benzodiazepine site agonists
TargetsGABA-A receptor; benzodiazepine site
Therapy Area/IndicationsAnxiety
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsAnxiety

Other Information

ATC CodeN/A
Related LinksN/A